Exane Derivatives Increases Holdings in Cronos Group Inc (NASDAQ:CRON)
Exane Derivatives grew its position in shares of Cronos Group Inc (NASDAQ:CRON) by 68.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 45,303 shares of the company’s stock after purchasing an additional 18,379 shares during the quarter. Exane Derivatives’ holdings in Cronos Group were worth $724,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in the company. Gables Capital Management Inc. increased its position in shares of Cronos Group by 20.0% during the 1st quarter. Gables Capital Management Inc. now owns 3,600 shares of the company’s stock valued at $66,000 after purchasing an additional 600 shares during the last quarter. Focu ...